Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Observational × osimertinib × Clear all

Status

Completed 6 Unknown 5 Recruiting 2 Suspended 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 55 Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Surveys and Questionnaires 34 Blood Specimen Collection 19 Specimen Handling 10 Radiotherapy 10 Magnetic Resonance Spectroscopy 8 Interviews as Topic 8 Data Collection 8 Surgical Procedures, Operative 7 Observation 7 Biopsy 5 ribociclib 4 palbociclib 4 Watchful Waiting 4 Trastuzumab 4 Therapeutics 4 Positron Emission Tomography Computed Tomography 4 Mental Status and Dementia Tests 4 Immunotherapy 4 Immune Checkpoint Inhibitors 4 X-Rays 3 Tomography, X-Ray Computed 3 Restraint, Physical 3 Radiosurgery 3 Mastectomy, Segmental 3 Mass Screening 3 Liquid Biopsy 3 Hepatectomy 3 Hematologic Tests 3 Exercise 3 Drug Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05103605 2025-12-01

POSITHES

AstraZeneca

Active not recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡